Stock Chart
RXRX
Type: SELL wallstreet
Strike: $7
Premium: $1.36
Expiry: Jan 15, 2027
Target: $7
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About RXRX - Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Key Statistics
More RXRX Analysis
This RXRX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track RXRX's price movements with trendlines, gamma walls, and key support/resistance levels.